ABO Blood Group System: Its Association with Anthropometric Indices among Young Adults of Yoruba Ethnicity

Introduction: The ABO blood group system is unique in immunology and haematology because it is the only system in which antibodies are consistently and predictably present in the serum of normal individuals whose red cells lack the antigens. Several epidemiological studies have reported that the distribution of different ABO blood groups vary markedly among the populations of different geographical areas reflecting racial differences. Aims: The aim of this study was to determine the association between ABO blood group and anthropometric indices among apparently healthy young adults of Yoruba ethnicity. Study Design: This is a cross-sectional descriptive study. Place and Duration of Study: The study was carried out at Department of Physiological Sciences and University Health Centre, Obafemi Awolowo University, Ile-Ife between May 2016 to June 2017. Methodology: Eighty apparently healthy young adults who were purposely selected participated in the study after screening for the ABO blood groups following the standard protocol. They were divided into four equal groups; 20 in each of blood groups A, B, AB and O who were age- and sex - matched. The weight (kg) and height (cm) of the participants were measured following standard protocol. Body mass index (BMI) and body surface area (BSA) were estimated from weight and height using Quetelex and Mosteller formulae respectively. Chi-square was used to compare grouped data while the comparison of means of parameters among the four blood groups was done using Analysis of Variance (ANOVA). A p-value of < 0.05 was taken statistically significant. Results: Out of the total 80 participants, 15% were males. The mean ± SD of height(m) of participants with blood groups A, B, O and AB were 1.65 ± 0.06, 1.63 ± 0.08, 1.62 ± 0.08 and 1.63 ± 0.08 (F= 0.349, p= 0.790) respectively. The mean ± SD of weight(kg) of the participants with blood group A,B, O and AB were 56.15 ± 8.71, 56.00 ± 11.21, 57.10 ± 12.73 and 58.05 ± 10.35 (F= 0.154, p= 0.927) respectively. The mean ± SD of BMI in kg/m2 for blood groups A, B, O and AB were 20.74 ± 3.22, 20.86 ± 2.91, 21.79 ± 5.10 and 21.91 ± 4.21 (F= 0.472, p= 0.703) respectively while the mean ± SD of BSA (m2) for blood group A, B, O and AB were 1.60 ± 0.12, 1.59 ± 0.19, 1.60 ± 0.18 and 1.62 ± 0.15 (F= 0.098, p= 0.961) respectively. Conclusion: AB Blood group may be predisposed to metabolic syndrome due to the higher mean of weight, BSA and BMI found in this group.

Chronic Lymphocytic Leukaemia: A-Twenty-Years Experience and Problems in Ile-Ife; South-Western Nigeria

Aim: To investigate the usefulness of some clinical and laboratory parameters in assessing the prognosis and survival of CLL in a resource-limited setting. Methods : Between September 1986 and March 2007; 79 consecutive patients were retrospectively studied. Diagnosis was based on clinical and haematological findings. Results : A total of 79 patients; aged 30 to 81 (median = 60) years were managed. There were 34 males and 45 females (ratio = 0.8:1). About 86.1were aged above 50 years. Massive splenomegaly and hepatomegaly were recorded in 70.9and 29.1of patients; respectively. More than 63presented in stage C. Anaemia was recorded in 74.7. Haematocrit correlated negatively with WBC but positively with platelet count. The spleen correlated positively with liver. The overall survival at 2 years was 70.2. Logistic regression showed that younger age; male sex; higher haematocrit; and lower platelet count improved survival; while lower WBC; moderate hepatomegaly and splenomegaly conferred survival advantage. Conclusion : It could be concluded that massive splenomegaly is a common finding in the majority of our patients. Non availability of immunophenotyping facility is a major constraint

AIDS-related lymphomas in Nigeria

Aggressive non-Hodgkin's lymphoma (NHL), including primary central nervous system (CNS) lymphoma, lymphoblastic lymphoma and non-endemic Burkitt's lymphoma have been recognized as AIDS-defining cancers in most developed countries. However, HIV/AIDS epidemics appear not to have been associated with higher incidence of lymphomas in Africa. We therefore carried out this study to highlight the significance or otherwise of HIV/AIDS epidemics in the pathogenesis of lymphomas in a population of Nigerians with the disease. Since January 1993 to the present, all patients with haematologic cancers are routinely screened (following appropriate counseling) for HIV infection. Patients with a histological diagnosis of malignant chronic lymphoproliferative diseases {non-Hodgkin lymphoma (NHL), chronic lymphocytic leukaemia (CLL), Burkitt's lymphoma (BL) and Hodgkin lymphoma (HL)} at the Obafemi Awolowo University Teaching Hospitals' Complex, Ile-Ife from January 1993 to August 2008 were noted. Those patients confirmed to be HIV/AIDS positive among the cohort with lymphomas were retrospectively studied using their clinical case notes. Data obtained were analyzed using appropriate descriptive and inferential statistics. A total of 391 patients were histologically confirmed to have lymphoma {NHL-109, (27.9 percent); CLL-76, (19.4 percent); BL-178, (45.5 percent) and HL-28, (7.2 percent)} during the study period. Nine patients (2.3 percent) were confirmed to be HIV- positive, all within the age bracket 24-60 (median = 50) years. Six of these, five males and one female, ages 24-60 (median = 37.5) years, had NHL while another three, all females (age 50 - 68years; median = 56 years) had CLL. None of the patients with HL and BL were HIV positive. Patients with NHL presented at advanced stage of the disease (at least clinical stage IIIb), and all those with CLL presented at stage C of the International Working Party Classification. All the HIV-positive patients ...